Nasal sprays help deliver the drug through the nose in the nasal cavity to treat allergies and other problems related to brain inflammation, diabetes, dental problems, and the central nervous system. Allergy is a condition in which the body’s immune system reacts abnormally to a foreign substance. Nasal spray drug products consist of therapeutically active ingredients or drug substances in the form of solution or suspension of excipients.
Different types of nasal sprays are available in the market, such as decongestion nasal spray, saline nasal spray, and steroid nasal spray. Decongestants are devices with drugs for treating nasal congestion and providing short-term relief from a blocked nose. Decongestion nasal sprays consist of drugs that open up the airways of the nasal part and help in the breathing process.
During the cold and dry winter season, saline nasal sprays are used to avoid problems related to a stuffy nose. These devices are used to treat sinusitis, nasal crusting, and thin secretions of liquid from the nose, which are formed due to bacterial infection and lead to the dryness of the nasal area. This device helps clean the nasal passage and mucus in that area due to cold.
Growing Patient Preference for Nasal Drug Delivery Due to Easy Administration and Better Efficacy to Drive Sea Water Nasal Spray Market Growth
Intranasal drug delivery routes are one of the most preferred drug delivery routes among patients and healthcare providers. This can be attributed to the noninvasive nature of this delivery route and the fact that drug absorption is higher through the nasal route. In addition, the nasal route offers a less hostile environment than the gastrointestinal route; this enables better absorption of drugs. Moreover, nasal drug delivery, unlike some other drug delivery, does not need any sterile method for administrating drugs into the body. The easy administration of these drugs is crucial in improving compliance with drug therapies among patients, which drives patient outcomes. Considering these factors, the preference for nasal drug delivery is increasing among patients and healthcare providers.
Regulatory Hurdles to Hamper Sea Water Nasal Spray Market Growth
Nasal drug delivery can be evaluated by various regulatory bodies, such as the US FDA and the European Medicines Agency (EMA). These agencies provide guidelines and regulations for any product before it is launched. They allow the performance of various in vitro test methods for determining the characterization of nasal drug products, which should come within an acceptable range as given by such regulatory bodies.
Nasal spray can be designed as per the dose requirement of drug substances for patients suffering from nasal or any other issues. Some aspects of nasal sprays may be exceptional in the case of formulation, manufacturing, container closure system, stability, controls of critical steps, intermediates, and drug products. These aspects should be measured carefully while developing a nasal spray program. Because of these changes, the ability of the product to treat patients may be affected.
Strict rules and regulations for nasal spray manufacturing products make it more challenging for manufacturers to get approval from regulatory agencies. The spray characteristics can be influenced by the design of the device and its handling.
Based on type, the sea water nasal spray market is segmented into isotonic sea water nasal spray, hypertonic sea water nasal spray, and hypotonic sea water nasal spray. In 2022, the hypertonic sea water nasal spray segment held the largest share of the market and is anticipated to register the highest CAGR during 2022–2030. Physicians recommend hypertonic nasal spray due to the higher concentration of salt that may draw fluid and mucus out more effectively. Hypertonic sea water nasal spray soothes nasal congestion during bacterial and viral infections, sinusitis, and colds. It helps to clear the nose of excessive secretions. Saline nasal spray moisturizes and soothes dried-up mucus membranes caused by staying in air-conditioned or overheated rooms. These advantages are expected to propel the demand for hypertonic sea water nasal sprays, thereby positively impacting the sea water nasal spray market.
Sea Water Nasal Spray Market: Competitive Landscape and Key Developments
Sterimar, LABORATOIRE DE LA MER, Gerolymatos International, Humer, Gifrer, GSK, Nacur Healthcare, Laboratoires Pharmaster, Bayer, and Sandoz are a few of the key companies operating in the sea water nasal spray market. These companies focus on product innovation strategies to meet evolving customer demands and maintain their brand name.
A few of the recent developments in the global Sea Water Nasal Spray market are mentioned below:
- In January 2023, Viatris Inc. announced that it had closed its Oyster Point Pharma and Famy Life Sciences acquisitions to establish a new Viatris Eye Care Division. This acquisition would help the company in its business expansion.
- In March 2023, Teva Pharmaceuticals launched additional strengths of Revlimid (lenalidomide capsules) in 2.5 mg and 20 mg for the generic version in the US. This product launch would help the company expand its product portfolio.
- In March 2021, Aurena Laboratories AB launched a portfolio of patent-protected Sparkling Saline Spray products for nasal relief, available for adoption by brand owners worldwide. Sparkling Saline Nasal Spray offers an exclusive drug-free nasal rinse based on saline or sea water, with carbon dioxide microbubbles that reach deep into the nasal passages to help lessen congestion and clear the nose. These elements have clinically proven benefits and offer a unique and refreshing experience that consumers value.